SEC Form 4 · accession 0001171843-17-005043
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian A Markison
Director
Period of report
Aug 11, 2017
Accepted (ET)
Aug 14, 2017 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $7.80 | Aug 11, 2017 | A | 12,539 | A | Aug 11, 2018 | Aug 11, 2024 | Common Stock, par value $0.01 per share | 12,539 | 12,539 | D |
| Restricted Stock UnitsF1 | — | Aug 11, 2017 | A | 7,051 | A | — | — | Common Stock, par value $0.01 per share | 7,051 | 7,051 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.